Cutaneous squamous cell carcinoma (ccSCC) research hub

Mechanisms of Resistance to anti-PD-1 Therapy in cutaneous Squamous Cell Carcinomas: Impact of Tumor Cell Plasticity on Promoting Myeloid Suppressor Cell Infiltration. A phase II single arm, unicenter study of cemiplimab in patients with locally advanced cSCCs.

This study is looking at how a medicine called cemiplimab (Libtayo) works in people with advanced skin cancer (cutaneous squamous cell carcinoma). Researchers want to understand why some people respond well and others don't, by studying blood and tumour samples.